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Introduction
Cartilage and bone defects are leading causes of dis-
ability. The economic burden of orthopedic repair 
exceeds 28 billion dollars per year in the United States 
alone,1 and the situation is similar in many other coun-
tries. Although artifi cial joints or metal inserts are 
widely utilized and in most cases work well, cell-based 
therapies based on tissue-engineered cartilage and bone 
beckon a new frontier for clinical treatment owing to 
their biocompatibility and long-term prognosis. Func-
tional tissue engineering2 involves an integrated use of 
three components — cells, scaffold material, and a bio-
reactor (Fig. 1), — in settings that mimic some elements 
of the in vivo environment. Synergistic interactions of 
biomimetic cues applied with temporal and spatial regu-
lation infl uence cell growth and biosynthesis and guide 
cellular development into functional replacement tissue 
constructs. This article discusses the design criteria and 
parameters essential for engineering cartilage and bone 
grafts as well as the current status and future perspec-
tive of the fi eld.
Tissue engineering
Cells
Cells are the actual “tissue engineers,” and several con-
siderations guide the choice of cell sources. The cells are 
ideally immunocompatible, such as autologous chon-
drocytes for cartilage repair. The use of chondrocytes, 
however, is limited by their availability and their capac-
ity for expansion in culture, as well as the need for a 
separate surgery to harvest the cells. The proliferative 
characteristics of autologous adult mesenchymal stem 
cells (MSCs) and the less invasive procedures for their 
procurement are thus considered important advantages. 
Although MSCs have better expandability than differ-
entiated cells, extensive expansion is known to decrease 
their biosynthetic capacity and multipotency.3 Clearly, 
cells used for tissue engineering need to be biosyntheti-
cally active. Mauck and coworkers reported that when 
bovine chondrocytes and bone-marrow derived MSCs 
from the same animals were cultured under identical 
conditions chondrocytes not only created a signifi cantly 
more functional tissue than MSCs they also maintained 
the improvement in biosynthetic and mechanical prop-
erties after 10 weeks of culture, by which time the MSCs 
had already reached a plateau.4 Therefore, optimizing 
the methods for MSC isolation, expansion, and differ-
entiation remain critical for their effective use in tissue 
engineering and regenerative medicine.
Scaffold
Scaffolds are designed to support spatially uniform cell 
attachment and to promote cell differentiation. Chemi-
cal properties that determine surface molecules and 
degradation patterns and structural properties such as 
pore size, orientation, and void volume are important 
in this respect. Scaffolds also serve as logistic templates 
for guiding tissue formation. The incorporation of regu-
latory molecules such as growth factors, along with the 
mechanical properties of the scaffolds at various hierar-
chical levels, plays major roles in molecular and bio-
physical regulation of cell differentiation. For example, 
fi ber alignment could be optimized to enhance the in 
vitro formation of intervertebral disc and meniscus 
tissue constructs.5,6 Hydrogels, with their ability to main-
tain cells in their spherical shape, were shown to be 
benefi cial in supporting the chondrogenic phenotype.7 
For cartilage and bone tissue engineering, scaffold 
materials need to have appropriate mechanical proper-
ties that sustain load, and their degradation should cor-
relate with advances in tissue growth. For example, silk 
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functionality of the tissue. Cartilage provides lubrica-
tion and sustains load by its ability to pressurize fl uid 
within its matrix. The charged macromolecules [pro-
teoglycans and glycosaminoglycans (GAGs)] provide 
hydration and electrostatic load, whereas the collagen 
network provides tension that keeps in balance the 
tissue swelling that would result from pressurization. 
Therefore, functional indicators of engineered cartilage 
grafts include the appropriate GAG and collagen con-
tents, adequate compressive moduli, and frictional coef-
fi cients. It is also important to monitor the spatial and 
temporal development of the tissue matrix to achieve 
mechanical competence along with the capacity for 
integration with host tissues. The following sections 
provide some examples of the design considerations for 
scaffold materials and bioreactors.
Scaffold
Naturally occurring biomaterials, such as collagen, 
provide appropriate biological cues to guide cell fate. 
However, collagen scaffolds are impaired by their 
poor mechanical integrity. Meinel et al. found silk scaf-
folds to be more chondrogenic than collagen scaffolds, 
possibly because of their higher porosity and better 
maintained structure and mechanical properties15 
(Fig. 3A). Porous scaffolds can also be combined 
fi broin can be modifi ed to have pore sizes8 ranging from 
470 to 940 µm and can be functionalized, mineralized, 
or used as a hydrogel.9 Custom-designed materials with 
appropriate structural, chemical, mechanical, and signal 
transmission properties are currently being developed. 
Further advances are being made by incorporating con-
trolled delivery of multiple growth factors or genes.
Bioreactor
In addition to scaffolds, bioreactors provide a biomi-
metic environment for optimizing cell functions (Fig. 2). 
They enhance nutrient transport and waste removal and 
supply the necessary regulatory signals, such as dynamic 
compressive loading for cartilage and hydrodynamic 
shear for bone. For example, fl uid shear has been shown 
to promote osteopontin and osteocalcin gene expres-
sion in MSCs,10 and perfusion bioreactors have been 
designed to provide mass transport and shear in cul-
tured constructs to promote osteogenesis. Bioreactors 
can also facilitate seeding in three-dimensional scaffolds 
where uniform distribution would otherwise be diffi -
cult.11 When designing bioreactors, one also has to 
consider environmental factors such as gas exchange, 
temperature control, and long-term sterility. The ability 
for online evaluation of tissue development is also ben-
efi cial, such as noninvasive imaging12,13 and mechanical 
testing.14 For cartilage and bone tissue engineering bio-
reactors, the magnetic resonance imaging (MRI) and 
microcomputed tomography (micro-CT) are among the 
most favored imaging options.
Cartilage tissue engineering
To engineer “successful” cartilage replacements, several 
outcome measures are important for determining the 
Fig. 1. Main components of tissue engineering
Fig. 2. Examples of bioreactor designs. Clockwise from top 
left: Spinner fl ask bioreactor with constructs threaded to long 
needles and on a magnetic spinning plate. Dynamic deforma-
tional loading device with an eccentric cam that loads samples 
in a 60-mm culture dish. (Courtesy of Dr. Clark Hung) Perfu-
sion bioreactor with six wells, each perfused at a well-defi ned 
fl ow rate. (Courtesy of Dr. Chris Cannizzaro) Rotating vessel 
bioreactor where the vessel rotation maintains the cultured 
tissue constructs in a state of free suspension and exposed to 
dynamic changes in fl uid pressure and velocity. (Courtesy of 
Sam Ogden)
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with hydrogels to create heterogeneous cartilage 
constructs.16
Nutrient supply and growth factors
Although cartilage maintains chondrocytes in a rela-
tively anaerobic environment, studies have demon-
strated that a suffi cient supply of oxygen and nutrients 
is essential for chondrocyte anabolism.17,18 Furthermore, 
growth factors modulate the expansion and chondro-
genic phenotype in both chondrocytes and MSCs. Pei 
and coworkers demonstrated that initial treatment with 
fi broblast growth factor-2 (FGF-2) and transforming 
growth factor-β1 (TGFβ1) dedifferentiated bovine 
articular chondrocytes and promoted cell expansion, 
whereas insulin-like growth factor-1 (IGF-1) redifferen-
tiated these cells and promoted the chondrogenic phe-
notype19 (Fig. 3B). This sequential treatment of growth 
factors appears to be important in promoting the chon-
drogenic phenotype, as it was shown by Byers et al. that 
transient exposure of TGFβ3 enhances the mechanical 
property of chondrocyte-laden hydrogels.20
Mechanical regulation
To mimic the physical environment in vivo, many groups 
have developed bioreactors to apply mechanical stimu-
lation to the tissue-engineered constructs. Providing 
laminar shear fl ow with rotating vessel bioreactors 
enhanced biosynthesis as well as mechanical proper-
ties21 (Fig. 3C). Bioreactors also improved mass trans-
port in the constructs. It appears that the increased 
nutrient supply can interact synergistically with the 
mechanical signals to advance tissue growth. For 
example, by combining dynamic deformational loading 
and TGFβ1, chondrocyte-laden agarose demonstrated 
an almost threefold increase in compressive modulus 
over free swelling controls22 (Fig. 3D).
Integration
To remain functional in vivo, an engineered construct 
has to integrate with the host tissue. Mature articular 
cartilage, however, does not integrate well with host 
tissue, which may lead to construct degeneration follow-
ing implantation. Obradovic and coworkers tested the 
integration properties using an in vitro explant ring 
model where the engineered construct (or cartilage 
explant) was inserted into an explant ring (Fig. 3E) and 
monitored in culture.23 It was found that developing 
constructs (i.e., within 1 week of culture) integrated 
markedly better with the explant rings than did more 
mature constructs (i.e., after 5 weeks of culture). Further 
examination indicated that proliferating cells at 
the edge of developing constructs were important 
for the remodeling of the integrating interface and 
for the formation of the tissue bond that provided 
integration.
Bone tissue engineering
The clinical need for bone grafts has motivated the 
development of biomaterials and bioreactor systems 
that maximize the potential of mesenchymal stem cells 
to exhibit a differentiated osteoblastic phenotype and 
Figure 3. Cartilage tissue engineering. A 
Effects of scaffold material.15 Inset SEM 
image of the scaffold. B Effect of mechan-
ical stimulation on compressive modulus21 
(*P < 0.001 vs. rotating vessel bioreactor). 
C Effects of growth factor on GAG pro-
duction.19 *Signifi cance of transforming 
growth factor-β1/fi broblast growth factor-
2 [(+)TGFβ1/FGF-2]. †Signifi cance of 
FGF-2. ‡Signifi cance of IGF. D Interac-
tion of growth factors and mechanical 
stimulation. Open bars, day 0; gray bars, 
day 14; black bars, day 35. *Signifi cant 
difference from day 0. †Signifi cant differ-
ence of loaded constructs in the same 
group at the same time point. §Signifi cant 
difference from the control construct at 
the same time point.38 Inset Percentage 
increase at day 35. *Signifi cant difference 
from other groups. E Integration proper-
ties of engineered construct with cartilage 
explant23
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form functional bone tissue. Various studies have dem-
onstrated that cell differentiation and the quality of the 
engineered graft are infl uenced by the scaffold proper-
ties and application of biophysical stimuli.
Scaffolds
Scaffold biochemistry and degradation properties criti-
cally infl uence the osteogenic capacity of MSCs. For 
example, various studies have demonstrated that incor-
porating mineralized components such as hydroxyapa-
tite into scaffold structure increased the expression of 
osteoblastic markers. When nonmineralized scaffolds 
were used, human MSC-seeded collagen sponges exhib-
ited considerably less mineralized deposits than silk 
scaffolds because they degrade more quickly and are 
unable to provide the proper structure for tissue devel-
opment over time.24 Silk substrates with varying pore 
sizes were used to determine the effect of scaffold 
microarchitecture with bone marrow-derived human 
MSCs.25 Upon exposure to osteogenic factors, the MSCs 
produced mineralized nodules in all silk scaffolds; 
however, the size and distribution of these nodules were 
infl uenced by the initial pore structure of the silk scaf-
folds. Specifi cally, in scaffolds with pore sizes of 100–
200 µm the trabecular nodules were very small and 
highly connected. When pore sizes of 400–500 µm were 
used the sizes of the nodules increased, and they exhib-
ited an open structure that more closely resembled that 
of native bone. Intermediate pore sizes resulted in tra-
beculae with transitional architecture (Fig. 4A).
Mechanical regulation
The quality of tissue-engineered bone grafts is affected 
by the uniformity of cell growth and mineral distribu-
tion throughout the scaffold. Limited nutrient transfer 
in static culture results in signifi cantly inhomogeneous 
cell distribution. Bioreactors improve nutrient transfer 
to cells by providing media perfusion through the con-
structs. An intrinsic effect of convection is the shear 
stress, a biophysical stimulus imparted to cells. Various 
studies done in two-dimensional systems demonstrate 
that shear stress can be mechano-transduced by osteo-
blasts, osteocytes, and undifferentiated stem cells to 
result in increased mineralization and up-regulation of 
osteogenic gene expression.26 Similarly, higher fl ow 
during culture improves the quality of engineered bone 
grafts. To decouple the effects of increased nutrient 
transfer from increased shear stress, Sikavitsas et al. 
utilized dextran molecules to obtain culture media 
of varying viscosities.27 Rat osteoblasts demonstrated 
enhanced mineralization in tissue constructs subjected 
to increased shear (with comparable levels of nutrient 
transfer) (Fig. 4B). It should be noted, however, that 
despite the improvement in graft sizes and homogeneity 
using perfusion bioreactors, it is not yet possible to grow 
grafts more than several millimeters thick.
In vivo studies
A major consideration for repairing in vivo defects is 
related to the forces to which the tissue engineered 
grafts would be exposed. Non-load-bearing sites are 
generally considered more easily treatable as the 
mechanical competence of the graft is not critical to its 
functionality. Meinel et al.28 treated the rat calvarium 
using human MSC-seeded silk scaffolds. There was 
signifi cant improvement in the quality of bone reg-
eneration when tissue-engineered constructs were used 
relative to cell-seeded scaffolds or scaffolds alone 
(Fig. 4C). In the latter two cases, there appeared to 
be little integration between the host tissue and the 
graft. In contrast, when a tissue-engineered graft was 
used to treat a rat femoral defect, micro-CT analysis 
suggested complete graft–host integration (Fig. 4D), 
indicating that the biochemical or mechanical differ-




Practical applications seldom require engineered grafts 
that are compositionally homogeneous. Rather, it 
may be necessary to obtain grafts that approximate the 
natural tissue stratifi cation and hierarchical organiza-
tion or that achieve integration between different tissue 
types in vivo. Hence, osteochondral grafts are designed 
to serve as complex tissues that exhibit a transient of 
properties between articular cartilage and the underly-
ing trabecular bone. One motivation for this approach 
was to circumvent poor cartilage–cartilage integration 
and take advantage of the native healing properties of 
bone.
In recent studies, chondrocyte-laden hydrogels were 
physically infused into an underlying, acellular, bony 
substrate that could be used as an attachment device.30 
MSCs are particularly advantageous for the formation 
of osteochondral constructs by virtue of their ability 
to differentiate into both cell types. Predifferentiated 
MSCs, under separate optimizing conditions for bone 
or cartilage, may be sutured together and cultivated in 
culture medium containing supplements essential to the 
development along both lineages. Tuli et al.31 reported 
the growth of osteochondral constructs from hMSCs by 
press-fi tting high-density chondrifying hMSCs into a 
scaffold and seeding the remaining regions of the scaf-
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Fig. 4. Bone tissue engineering. A Upper 
panel (from left to right): Silk scaffolds of 
small, intermediate and large pore sizes. 
Lower panel: Corresponding trabecular 
structure of bone mineral formed by mes-
enchymal stem cells (MSCs) in the silk 
scaffolds. Trabecular microarchitecture 
more closely approximates that of native 
bone with the larger pore sizes. B Histo-
logical sections of rat stromal osteoblasts 
cultured in static conditions (upper left), 
fl ow with 0% dextran (upper right), 3% 
dextran (lower left) and 6% dextran 
(lower right) indicating that increased 
shear increases the cellular response. 
(Adapted from Sikavistas27). C Repair of 
a rat calvarial defect with tissue-engi-
neered bone (upper left), human MSCs 
(hMSCs) seeded scaffolds (upper right), 
scaffolds only (lower left), or untreated 
(lower right).28 D Rat femoral defect: 
untreated (left) or treated with tissue-
engineered construct (right)29
Fig. 5. Osteochondral tissue engineering. A 
Advanced bioreactor system capable of provid-
ing spatially regulated perfusion and dynamic 
compression to hMSC-seeded biphasic osteo-
chondral grafts. B Unseeded biphasic (gel/scaf-
fold) construct cultured with dye for 30 min in a 
bioreactor with perfusion only (left) or perfusion 
and compression (right), demonstrating trans-
port to the gel region with compression. C Undif-
ferentiated MSCs were cultured in biphasic 
scaffolds for 5 weeks in chondroinductive 
medium. Alcian blue stains show chondrocytic 
differentiation only in the gel region (upper 
panel). Type I collagen staining indicate osteo-
genic differentiation only in the scaffold region 
(lower panel). D Anatomically shaped human 
mandibular condyle made from trabecular 
bone
fold with osteo-induced hMSCs resulting in single-unit 
grafts with a gradient of properties.
A biomimetic approach to osteochondral graft for-
mation should utilize biphasic constructs to recapitulate 
the structural and mechanical differences in the two 
tissue types. The sensitivity of hMSCs to their microen-
vironment facilitates spatial control of lineage com-
mitment within a single construct and potentially 
circumvents the need for predifferentiation of the cells. 
Human MSCs may be seeded into a gel (for cartilage) 
or solid porous scaffold (for bone) and subsequently be 
exposed to different mechanical stimuli (compression 
and perfusion respectively) for biophysical stimulation 
and improved nutrient transport. These multiple func-
tions are achieved using advanced bioreactors (Fig. 
5A). As a result, there was expression of lineage-
specifi c markers in different regions of biphasic grafts 
(agarose and decellularized trabecular bone) where 
human MSCs were seeded into the constructs32 (Fig. 
5C).
In vivo studies
Various animal models have investigated the plausibil-
ity of using osteochondral plugs for repairing focal 
defects in articular cartilage.33,34 These studies have 
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traditionally used terminally differentiated cell types 
(which produce better functional grafts than stem 
cell populations). However, Solchaga and coworkers35 
attempted to heal osteochondral defects in rabbits using 
autologous bone marrow vacuum-seeded into hyaluro-
nan-based biomaterials and implanted directly into 
defect site without in vitro culture. Their method 
depended on microenvironmental cues to guide cell dif-
ferentiation and resulted in the formation of regions of 
bone and cartilage. However, unseeded scaffolds also 
elicited a healing response, indicating that the bone 
marrow may have simply accelerated a process that was 
mediated by the body’s normal healing mechanisms. 
Currently, there remains a scarcity of publications dem-
onstrating the application of stem cell-derived osteo-
chondral constructs for repairing in vivo defects.
Anatomically shaped osteochondral grafts
There have been several meritorious approaches to 
recapitulating the complex, anatomically correct shapes 
in developing osteochondral constructs. The temporo-
mandibular joint (TMJ) condyle has been used exten-
sively as a model system because of its relatively small 
size and highly complex structure. A promising approach 
was reported by Alhadlaq et al.36 wherein rat MSCs 
were predifferentiated along different chondrogenic 
and osteogenic lineages prior to seeding into a stratifi ed 
gel molded in the shape of a cadaveric mandibular 
condyle. Another strategy is to combine clinical imaging 
technology such as CT or MRI to obtain patient-specifi c 
anatomical shapes that can then be molded into a bio-
material seeded with autologous cells (Fig. 5D). Such 
an approach circumvents issues of graft rejection via 
immune responses and is patient-specifi c. It also requires 
the use of highly advanced bioreactor designs to culti-
vate functional properties prior to implantation. For 
instance, Hung’s group37 obtained anatomically shaped 
patella grafts with bovine chondrocytes in the cartilagi-
nous phase and an acellular bony support. A bioreactor 
capable of imparting physiologically relevant stimuli 
to cells in the developing cartilage region is required 
for in vitro cultivation to improve the mechanical 
characteristics.
Conclusions and future perspectives
Much progress has been made in understanding the 
conditions required for directing cell differentiation and 
assembly into functional tissue structures. Studies of 
cells cultured on biomaterial scaffolds (providing struc-
tural and logistic templates for tissue formation) using 
bioreactors (providing environmental control, effi cient 
mass transport, and the necessary molecular and physi-
cal signals) played a major role in advancing our ability 
to direct cell behavior. The next step is to apply tech-
nologically advanced, biologically inspired tissue engi-
neering systems to cells that are easy to obtain, well 
characterized, and of interest for clinical use. It is likely 
that the increasing interactions between the fi elds of 
tissue engineering, developmental and adult biology, 
and medical sciences will help address the challenges 
ahead of us.
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